Tilray Signs Agreement with Leading Pharma Company Sandoz Canada

Tilray, wholly owned subsidiary of Privateer Holdings, has announced a partnership with one of the leading pharmaceutical companies in Canada called Sandoz Canada.

Under the terms of the signed agreement, Tilray  will gain exclusive rights to supply Sandoz Canada with non-combustible cannabis based medicines such as topicals and oral sprays. Sandoz Canada will distribute  product through their network of pharmacists, physicians, and patients across Canada.

Widening acknowledgment of cannabis products and its medicinal benefits is now prevalent in Canada. According to a report in September 2017 Health Canada, there are 235,621 registered medical marijuana in Canada. Tilray plans to develop new products for Sandoz Canada, which the company will then leverage to educate pharmacists and the public about the benefits of cannabis.

Related posts

Liberty Health Sciences to Bring Mary’s Medicinals Cannabis Products to Massachusetts

Editor

VividGro, a Pegasus Capital Advisors Portfolio Company, Announces Partnership with Merida Capital Partners

Editor

Diego Pellicer Worldwide, Inc. Executes Letter Of Intent To Purchase A Marijuana Infused Products Facility In Denver

CCT IMPACT Agent

Leave a Comment

%d bloggers like this: